Mixed germ cell tumor of central nervous system

Mixed germ cell tumor of the central nervous system (CNS) is a rare intracranial neoplasm composed of two or more different germ cell tumor components, such as germinoma, teratoma, embryonal carcinoma, yolk sac tumor (endodermal sinus tumor), and/or choriocarcinoma. These tumors predominantly arise in midline structures of the brain, most commonly in the pineal region and the suprasellar (above the pituitary gland) area. They belong to the broader category of intracranial germ cell tumors and are classified as non-germinomatous germ cell tumors (NGGCTs), which generally carry a less favorable prognosis compared to pure germinomas. Mixed germ cell tumors of the CNS primarily affect children, adolescents, and young adults, with a notable male predominance. Key symptoms depend on tumor location and may include signs of increased intracranial pressure (headaches, nausea, vomiting), visual disturbances (particularly with suprasellar tumors affecting the optic chiasm), diabetes insipidus and other endocrine dysfunction due to hypothalamic-pituitary axis involvement, and hydrocephalus caused by obstruction of cerebrospinal fluid flow. Parinaud syndrome (upward gaze palsy) is characteristic of pineal region tumors. Tumor markers such as alpha-fetoprotein (AFP) and beta-human chorionic gonadotropin (beta-hCG) in serum and cerebrospinal fluid are often elevated and aid in diagnosis. Treatment typically involves a multimodal approach including a combination of chemotherapy and radiation therapy, and in some cases surgical resection. Platinum-based chemotherapy regimens are commonly used, often followed by craniospinal or focal radiation therapy. The prognosis varies depending on the specific histological components present, tumor location, extent of disease, and response to initial treatment. Overall survival rates for mixed germ cell tumors are generally lower than for pure germinomas but have improved with modern combined treatment strategies. Long-term follow-up is essential to monitor for recurrence and manage treatment-related late effects, including neurocognitive and endocrine complications.

Common questions about Mixed germ cell tumor of central nervous system